SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-22-009191
Filing Date
2022-07-26
Accepted
2022-07-26 16:05:36
Documents
14
Period of Report
2022-07-25
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e7262208k.htm   iXBRL 8-K 27098
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 26170
3 GRAPHIC hgen_logo2.jpg GRAPHIC 4205
  Complete submission text file 0001214659-22-009191.txt   239664

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hgen-20220725.xsd EX-101.SCH 2935
5 XBRL LABEL FILE hgen-20220725_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE hgen-20220725_pre.xml EX-101.PRE 22343
8 EXTRACTED XBRL INSTANCE DOCUMENT e7262208k_htm.xml XML 3573
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 221107158
SIC: 2834 Pharmaceutical Preparations